The UMass Center for Clinical and Translational Science offers a host of services, tools and resources across the University's 5-campus system to enhance collaboration, research and data management.
The mission of the ATC is to apply the knowledge flowing from the latest biomedical discoveries to develop new ways to treat disease and then drive those therapies into clinical trials.
High quality translational research requires expertise in the design, analysis, and conduct of observational studies, randomized controlled trials, quasi-experimental designs, and complex laboratory studies. A key element of the BERD component is the Department of Quantitative Health Sciences, which fosters collaboration among existing clinical and basic science entities with the goal of shortening the time between laboratory breakthroughs and clinical applications.
Our Clinical Research Center is dedicated to efficient, reliable, and high-quality study support for UMass clinical investigators.
As the health care consulting division of UMass Medical School, Commonwealth Medicine uses academic research to make evidence-based recommendations. With our help, government agencies, nonprofits, and managed care organizations are able to meet today's health care challenges - and are prepared for what's to come.
A community engaged research approach can enable researchers and community partners to conduct research to improve health. To help both researchers and community partners using this approach, we have collected a wealth of information to assist with understanding health status and issues in Massachusetts communities, learning more about community-engaged research, and developing proposals for future work.
Conquering Diseases is the name given to a research project that hopes to discover the keys to better health in our community. The Conquering Diseases Program is a partnership between community members, the patients being cared for by the health professionals of UMass Memorial and the research community.
The Conquering Diseases Program consists of three components: a Clinical Research Volunteer Registry, a Biorepository, and a Community Resource Center. These three components are available to researchers, patients and community members alike.
The ultimate goal of Conquering Diseases is to gain a better understanding of the diseases our patients suffer from, how to prevent, and better treat these afflictions. The Conquering Diseases programs are supported by the National Center for Advancing Translational Sciences, National Institutes of Health
The UMCCTS Informatics Core is comprised of the Clinical Research Informatics Core and the Bioinformatics Core, both of which work closely with the Research Computing Division of UMass Medical School Information Services. Directed by faculty informatics leaders, the Cores innovate, develop new tools, provide consultations to invetigators, share resources with the national CTSA community, and teach in our educational programs. Research Computing integrates with the clinical system; supports data management and informatics tools; serves as the access hub for services, storage, and high-performance computing; and conducts training in information technology (IT) security and use of common tools.
The investigational pharmacists in the Investigational Drug Service (IDS) play a key role in facilitating subject safety for clinical trials being conducted at UMass Medical School (UMMS) and UMass Memorial Medical Center (UMMMC). The IDS provides the following services:
- Consultation with investigators pre-study and throughout conduct of trial, including assessment of appropriate charges for investigational services;
- Preparation of IDDF (drug data form);
- Aiding in procurement of investigational drugs;
- Receipt, storage, accountability, dispensing and return/destruction of all investigational drugs;
- Monitoring of all ongoing investigational drug activity by clinical researchers in the UMMS or on the campuses of UMMMC;
- Control and accountability of investigational drugs according to state and federal regulatory requirements, sponsor specifications and hospital pharmacy practice.
MassBiologics of UMMS' mission is to discover and develop products that will significantly improve public health. This includes products for smaller patient populations due to limited incidence of disease (orphan products), uncertain markets as new challenges to public health arise, or products for developing nations with limited resources and unique needs.
The Massachusetts Medical Device Development Center (M2D2) is a lifeline for the State's smaller medical device companies, offering inventors and executives easy, affordable, and coordinated access to world-class researchers and resources at the UMass Lowell and Worcester campuses.
The Meyers Primary Care Institute is committed to research across the lifespan, from childhood to advanced age. We conduct population-based research to inform policy and practice, promoting evidence-based care for the benefit of our community, and beyond.
The UMMS Office of Global Health (OGH) was founded in 2009 to enhance and expand UMMS research and training programs in global health improvement and disease prevention.
The availability of robust, affordable core services accelerates the pace of research across the entire translational spectrum.
The Small Molecule Screening Facility assists researchers in developing high-throughput (HT) screening assays, performs HT screens of chemical libraries to identify new small molecules that can be used to probe biological processes of interest.
Science Participation Research Center (SPRC)
The Science Participation Research Center (SPRC) seeks to engage special populations in clinical and translational research with strategies that reach out to investigators and community members using tailored, culturally responsive methods. Our mission is complementary to, but distinct from that of the UMCCTS Community Engagement and Research component, which seeks to develop scalable models of institutional infrastructure for community-responsive clinical and translational research.